Clinical Trials Logo

Filter by:
NCT ID: NCT06036329 Completed - Clinical trials for Obstructive Sleep Apnea

Whitsundays (Nasal) Mask Take Home Study (90 Days)

Start date: May 31, 2023
Phase: N/A
Study type: Interventional

The goal of this multi-site, prospective, randomized, double arm study without blinding is to test the usability of the Whitsundays mask system at home by patients with Obstructive Sleep Apnea. The main questions it aims to answer are: - How the Whitsundays masks performs in the home environment - What is the subject's first impression of the Whitsundays mask and what is their preference compared to their own mask - What is the difference between the subject's objective therapy data when using the Whitsundays mask compared to their own mask - Is there wear and tear of the Whitsundays mask and how frequently do the cushions need replacement Participants will be asked to use the Whitsundays mask for 90 days, answer questionnaires about the initial impression of the mask, the performance of the mask, and their preference compared to their own mask. Researchers will compare one group of subjects who will be provided with cushion replacements to another group who will only be provided with cushion replacements upon request to determine the need for cushion replacement, its frequency, and the reasons for cushion replacement during home usage.

NCT ID: NCT06036251 Completed - Stress Clinical Trials

COVID-19 Pandemic Induced Stress and Symptoms

Start date: February 1, 2023
Phase:
Study type: Observational

The previous survey of oncology patients at University of California, San Francisco in 2020-2021 found an alarmingly high symptom burden and high levels of stress and loneliness among respondents. This is a follow-up study with the same sample of oncology patients and survivors who participated in the previous study

NCT ID: NCT06034652 Completed - Hernia Clinical Trials

T-GENVIH-003 LTFU (Long Term Follow Up) Study

Start date: September 12, 2023
Phase:
Study type: Observational

The T-GENVIH-003 study will collect additional, longer term performance data of Gentrix® Surgical Matrix used for reinforcement of ventral hernia repairs from a subset population (i.e., the twenty-one minimally invasive surgical approach cases) from the prior T-GENVIH-002 study.

NCT ID: NCT06034548 Completed - Hypertension Clinical Trials

Diabetes and Hypertension Self Management Program

Start date: August 27, 2018
Phase: N/A
Study type: Interventional

The purpose of this R15 project is to test the feasibility and effectiveness of a 12-week diabetes and hypertension self-management program using trained health coaches.

NCT ID: NCT06034340 Completed - Anesthesia, Local Clinical Trials

Lidocaine Administration Using STAR Particles

Start date: March 19, 2023
Phase: N/A
Study type: Interventional

This study is being done to answer the question: Do STAR particles (tiny pieces of ceramic with small spikes) help numbing gel (a gel that helps you feel less pain) work more quickly to provide local anesthesia or numbing in a specific area? Research participants will provide feedback on how quickly the STAR particles with the numbing gel can provide anesthesia.

NCT ID: NCT06034301 Completed - Hypertension Clinical Trials

Pill Bottle vs Reminder App

Start date: September 18, 2023
Phase: N/A
Study type: Interventional

Current medication adherence interventions are minimally effective, which results in higher rates of morbidity and mortality for 45 million US adults who have hypertension and low adherence. This feasibility randomized controlled trial seeks to understand the efficacy of reminders and monitoring in the form of a mobile phone application vs usual care on medication adherence as well as the feasibility of the intervention and study procedures. This study will compare participants who use a mobile phone app that notifies them when to take their medications (intervention group) to participants who do not get assigned the app (control group) for 30 days. Medication adherence will be monitored using a Medication Event Monitoring System (MEMS) cap. Both groups will also receive the usual care, which will include giving participants a pamphlet about taking their medications. The long-term goal of this work is to improve antihypertensive medication adherence and to decrease morbidity and mortality. The objective of this application is to test the efficacy of the app based reminders and feedback. The hypothesis driving this research is that the intervention will be more effective than the usual care. The specific aims are as follows:

NCT ID: NCT06033664 Completed - Hypertension Clinical Trials

Grocery Prescription Program for Medicaid Adults With Hypertension or Type 2 Diabetes

Start date: November 6, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of a grocery prescription program in adults diagnosed with either Type 2 Diabetes Mellitus or Hypertension. Participants will enroll in Instacart Fresh Funds program. Once enrolled each week participants will select foods that are eligible in the Fresh Funds Program to be delivered to their home for 12 weeks. Participants will also participate in a survey at the beginning of the study and at the end of the study.

NCT ID: NCT06033313 Completed - Asthma Clinical Trials

Effects of Framing on Medication Beliefs, Intentions to Take Medication, Adherence, and Asthma Control

Start date: October 1, 2019
Phase: N/A
Study type: Interventional

The goal of this study is to examine the effects of framed mobile messages on young adults' beliefs about their daily Inhaled Corticosteroids (ICS), intentions to take their ICS, adherence, and asthma control. College students (18-29 years) who owned a mobile phone and had a diagnosis of asthma with a prescription for an ICS will be recruited. Participants will be randomized to receive either gain- or loss-framed mobile messages three times per week for eight weeks. Outcomes including beliefs, intentions, adherence, and asthma control will be assessed.

NCT ID: NCT06033079 Completed - Pneumonia Childhood Clinical Trials

Improving CarE for Community Acquired Pneumonia 1 (ICE-CAP2)

ICE-CAP2
Start date: November 20, 2020
Phase: N/A
Study type: Interventional

Children with pneumonia presenting to the emergency department at Monroe Carell Jr. Children's Hospital at Vanderbilt or Children's Hospital of Pittsburgh will be potentially eligible for study. During intervention periods, providers caring for enrolled children will be presented with a detailed decision support strategy that emphasizes management in accordance with national guideline recommendations. The anticipated study duration is 24 months and, as this study does not include direct contact with enrolled subjects, there is no anticipated follow up.

NCT ID: NCT06030219 Completed - Healthy Volunteers Clinical Trials

Microbiome Effect of Omadacycline on Healthy Volunteers

Start date: October 12, 2020
Phase: Phase 1
Study type: Interventional

The goal of this study is to assess microbiome changes associated with omadacycline vs. comparators (moxifloxacin or oral vancomycin). Using a phase I study design, healthy volunteers aged 18-40 years will be given a 10-day course of either omadacycline 450 mg days 1 and 2 followed by 300 mg PO once daily, moxifloxacin 400 mg once daily, or oral vancomycin 125 mg given four times daily. Stool will be collected at baseline, daily during therapy, and at two follow-up time periods (days 13-14 and days 30-32). DNA will be extracted from stool and used for qPCR biomass and microbial metagenomic experiments. Results from the study will provide definitive data on the microbiome effects of omadacycline versus comparator antibiotics.